» Articles » PMID: 2828656

Identification of the E5 Open Reading Frame of Human Papillomavirus Type 16

Overview
Journal J Virol
Date 1988 Mar 1
PMID 2828656
Citations 20
Authors
Affiliations
Soon will be listed here.
Abstract

Sequencing of the E5 open reading frame (ORF) of human papillomavirus type 16 revealed an additional nucleotide, a thymidine residue, at position 3903 compared with the original sequence (Seedorf et al., Virology 145:181-185, 1985). The additional T had two effects; first, in reading frame 2, in which the original E5 ORF was predicted, the additional T changed the reading frame downstream of position 3903 to create an ORF, which we designated E5, that terminated at position 4018 and potentially encoded a 52-amino-acid polypeptide. Secondly, in reading frame 3, a new ORF was created (positions 3807 to 4097), which we propose is the authentic papillomavirus type 16 E5 ORF. It contained a methionine residue and encoded an additional 82 amino acids. Both ORFs have been cloned into bacterial expression vectors (pATH), and the fusion proteins have been used to generate polyclonal antibodies in rabbits.

Citing Articles

Too many cooks in the kitchen: HPV driven carcinogenesis - The result of collaboration or competition?.

Kathleen W Tumour Virus Res. 2024; 19():200311.

PMID: 39733972 PMC: 11753912. DOI: 10.1016/j.tvr.2024.200311.


Structural dynamic studies on identification of EGCG analogues for the inhibition of Human Papillomavirus E7.

Aarthy M, Panwar U, Singh S Sci Rep. 2020; 10(1):8661.

PMID: 32457393 PMC: 7250877. DOI: 10.1038/s41598-020-65446-7.


The human papillomavirus 16 E5 gene potentiates MmuPV1-Dependent pathogenesis.

Torres A, Spurgeon M, Bilger A, Blaine-Sauer S, Uberoi A, Buehler D Virology. 2019; 541:1-12.

PMID: 31826841 PMC: 7024000. DOI: 10.1016/j.virol.2019.12.002.


The E5 proteins.

DiMaio D, Petti L Virology. 2013; 445(1-2):99-114.

PMID: 23731971 PMC: 3772959. DOI: 10.1016/j.virol.2013.05.006.


Analyses of variant human papillomavirus type-16 E5 proteins for their ability to induce mitogenesis of murine fibroblasts.

Nath R, Mant C, Kell B, Cason J, Bible J Cancer Cell Int. 2006; 6:19.

PMID: 16899131 PMC: 1569872. DOI: 10.1186/1475-2867-6-19.


References
1.
SANGER F, Nicklen S, Coulson A . DNA sequencing with chain-terminating inhibitors. Proc Natl Acad Sci U S A. 1977; 74(12):5463-7. PMC: 431765. DOI: 10.1073/pnas.74.12.5463. View

2.
Androphy E, Hubbert N, Schiller J, Lowy D . Identification of the HPV-16 E6 protein from transformed mouse cells and human cervical carcinoma cell lines. EMBO J. 1987; 6(4):989-92. PMC: 553493. DOI: 10.1002/j.1460-2075.1987.tb04849.x. View

3.
Gissmann L, Wolnik L, Ikenberg H, Koldovsky U, Schnurch H, zur Hausen H . Human papillomavirus types 6 and 11 DNA sequences in genital and laryngeal papillomas and in some cervical cancers. Proc Natl Acad Sci U S A. 1983; 80(2):560-3. PMC: 393419. DOI: 10.1073/pnas.80.2.560. View

4.
Danos O, Engel L, Chen E, Yaniv M, Howley P . Comparative analysis of the human type 1a and bovine type 1 papillomavirus genomes. J Virol. 1983; 46(2):557-66. PMC: 255158. DOI: 10.1128/JVI.46.2.557-566.1983. View

5.
Durst M, Gissmann L, Ikenberg H, zur Hausen H . A papillomavirus DNA from a cervical carcinoma and its prevalence in cancer biopsy samples from different geographic regions. Proc Natl Acad Sci U S A. 1983; 80(12):3812-5. PMC: 394142. DOI: 10.1073/pnas.80.12.3812. View